gene therapy news from FierceBiotech
NewsArk shares soar on gene therapy data
A late-stage study of Ark Therapeutics' gene therapy for cancer posted significant survival benefits for volunteers with operable high grade glioma, sending its stock soaring 69 percent on the news. Read more...
Introgen files first gene therapy for FDA approval
After 14 years of research, Introgen Therapeutics is asking the FDA to give its BLA for a gene-based therapy for head and neck cancer - Advexin -- a priority review. Experts in the field told the Read more...
Florida coffers going dry as lawmakers deny funds
Lawmakers in Florida have opted against pumping a fresh $25 million into its Innovation Incentive Fund, one of the most singularly Read more...
Is Sanofi preparing a bid for Oxford BioMedica?
Investors have focused their attention on Oxford BioMedica, a struggling UK developer that is the Read more...
Merck's HIV vaccine linked to higher infections rate
Merck researchers have gone deep into the data for its recently shelved HIV vaccine and found evidence that the therapy may have actually made patients more likely to get an infection. Looking at the Read more...
Nobel Prize goes to gene targeting trio
As a child, Mario Capecchi spent four years on the streets in his native Italy, surviving by stealing or begging for food. Today, he's one of three scientists--the other two are Oliver Smithies and Read more...
| Press ReleasesPRESS RELEASE: PET scans show gene therapy normalizes brain function in Parkinson's patients PET scans show gene therapy normalizes brain function in Parkinson's patients MANHASSET, NY - Brain scans used to track changes in a dozen patients who received an experimental gene therapy show Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets